Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Profiling of CYP4Z1 and CYP1B1 expression in bladder cancers
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Ahmed M. M. Youssef, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions
Bhavisha Doshi, Sarah R. Athans, Anna Woloszynska‐Read
Oncogenesis (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Phytochemistry and Anticancer Effects of Mangrove (Rhizophora mucronata Lam.) Leaves and Stems Extract against Different Cancer Cell Lines
Ahmed M. M. Youssef, Doaa A. M.‎ Maaty, Yousef M. Al-saraireh
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 4-4
Open Access | Times Cited: 29
Phytochemical Analysis and Profiling of Antitumor Compounds of Leaves and Stems of Calystegia silvatica (Kit.) Griseb.
Ahmed M. M. Youssef, Doaa A. M.‎ Maaty, Yousef M. Al-saraireh
Molecules (2023) Vol. 28, Iss. 2, pp. 630-630
Open Access | Times Cited: 18
Pathological and pharmacological functions of the metabolites of polyunsaturated fatty acids mediated by cyclooxygenases, lipoxygenases, and cytochrome P450s in cancers
Yi-Wen Meng, Jun‐Yan Liu
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108612-108612
Closed Access | Times Cited: 6
Application of a CYP1B1-Targeted NIR Probe for Breast Cancer Diagnosis, Surgical Navigation, and CYP1B1-Associated Chemotherapy Resistance Monitoring
Zhihao Wu, Tao Shi, Qi Shao, et al.
Molecular Pharmaceutics (2025)
Closed Access
Heme-thiolate monooxygenase cytochrome P450 1B1, an old dog with many new tricks
Jong-Won Kim, Hung‐Chun Tung, Bin Yang, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100045-100045
Closed Access
Phytochemical Analysis and Profiling of Antioxidants and Anticancer Compounds from Tephrosia purpurea (L.) subsp. apollinea Family Fabaceae
Ahmed M. M. Youssef, Doaa A. M.‎ Maaty, Yousef M. Al-saraireh
Molecules (2023) Vol. 28, Iss. 9, pp. 3939-3939
Open Access | Times Cited: 14
Cytochrome P450 and Other Drug-Metabolizing Enzymes As Therapeutic Targets
R. Foti
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 8, pp. 936-949
Open Access | Times Cited: 12
ZNF276 promotes the malignant phenotype of breast carcinoma by activating the CYP1B1-mediated Wnt/β-catenin pathway
Ting Lei, Wenwu Zhang, Yongyin He, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 18
Cytochrome 4Z1 Expression Is Correlated with Poor Prognosis in Patients with Cervical Cancer
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Ahmed M. M. Youssef, et al.
Current Oncology (2021) Vol. 28, Iss. 5, pp. 3573-3584
Open Access | Times Cited: 21
Cytochrome P450 1B1 Overexpression in Cervical Cancers: Cross-sectional Study
Fatemah O. F. O. Alshammari, Yousef M. Al-saraireh, Ahmed M. M. Youssef, et al.
Interactive Journal of Medical Research (2021) Vol. 10, Iss. 4, pp. e31150-e31150
Open Access | Times Cited: 18
Exploring human CYP4 enzymes: Physiological roles, function in diseases and focus on inhibitors
Manzhen Zhou, Junda Li, Jinyi Xu, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103560-103560
Closed Access | Times Cited: 6
Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Omar H. Abu-azzam, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2898-2898
Open Access | Times Cited: 6
Cytochrome 4Z1 Expression is Associated with Poor Prognosis in Colon Cancer Patients
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Ahmed M. M. Youssef, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 5249-5260
Open Access | Times Cited: 15
Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Ahmed M. M. Youssef, et al.
Breast Cancer Targets and Therapy (2021) Vol. Volume 13, pp. 565-574
Open Access | Times Cited: 14
Enhancing the invasive traits of breast cancers by CYP1B1 via regulation of p53 to promote uPAR expression
Yeo‐Jung Kwon, Tae-Uk Kwon, Sangyun Shin, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 1, pp. 166868-166868
Open Access | Times Cited: 5
There and Back Again: A Perspective on 20 Years of CYP4Z1
John P. Kowalski, Allan E. Rettie
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 6, pp. 498-507
Open Access | Times Cited: 1
Cytochrome 4Z1 Expression Connotes Unfavorable Prognosis in Ovarian Cancers
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Anas Satari, et al.
Medicina (2022) Vol. 58, Iss. 9, pp. 1263-1263
Open Access | Times Cited: 8
Design and Synthesis of Novel Near-Infrared Fluorescence Probes Based on an Open Conformation of a Cytochrome P450 1B1 Complex for Molecular Imaging of Colorectal Tumors
Dongmei Chen, Ruining Li, Qi Shao, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16032-16050
Closed Access | Times Cited: 4
Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer
Xiaodong Song, Xin Sheng, Yucong Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 7
Monitoring of autoantibodies against CYP4Z1 in patients with colon, ovarian, or prostate cancer
Christopher Khayeka–Wandabwa, Xiaoshuang Ma, Yingjie Jia, et al.
Immunobiology (2022) Vol. 227, Iss. 2, pp. 152174-152174
Closed Access | Times Cited: 6
Glypican-3 Differentiates Intraductal Carcinoma and Paget’s Disease from Other Types of Breast Cancer
Fatemah O. F. O. Alshammari, Anas Satari, Ahmed Aljabali, et al.
Medicina (2022) Vol. 59, Iss. 1, pp. 86-86
Open Access | Times Cited: 6
Targeting Cytochrome P450 Enzymes in Ovarian Cancers: new approaches for Tumour-Selective Interventions
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Omar H. Abu-azzam, et al.
(2023)
Open Access | Times Cited: 3
Regulatory mechanisms and potential medical applications of HNF1A-AS1 in cancers.
Yang Zhang, Jiang Shi, Junfang Luo, et al.
PubMed (2022) Vol. 14, Iss. 6, pp. 4154-4168
Closed Access | Times Cited: 5
Improved methods for the detection of heme and protoporphyrin IX adducts and quantification of heme B from cytochrome P450 containing systems
Robert Pelletier, Allan E. Rettie, John P. Kowalski
Journal of Chromatography B (2023) Vol. 1231, pp. 123921-123921
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top